Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLK1 (clone DI-2E-1G4I). We employs the Retrovirus (EF1α-TurboGFP-c-Fos-XbaI) vector components and the SynExpress system of the Exons Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DLK1
Clone
DI-2E-1G4I
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
TurboGFP
Promoter
EF1α
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.88
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.